The drug companies have already agreed to contribute the $80 billion, in part, by discounting drugs to Medicare beneficiaries, but Congress is looking to close a gap that forces many Medicare patients to pay a significant portion of their prescription costs, according to the report. Under the new proposal, Congress may up the discount from 50 percent to 75 percent.
Lobbyists said that in order to completely close the gap, which is Congress's goal, other industries will have to chip in to help offset funds, according to the report.
Supporters of the overhaul have said that in spite of the increased contributions, pharmaceuticals and the biotech industry stand to profit from the reform as they will have access to 30 million new customers as part of the healthcare bills.
Read the WSJ's report on pharmaceutical contributions to healthcare reform.
Democrats Look to Pharmaceutical Industry to Add $10B for Healthcare ReformWritten by Staff | January 15, 2010
Congressional Democrats have asked officials from the pharmaceutical industry to contribute an additional $10 billion, on top of a promised $80 billion, to help offset the cost of the healthcare overhaul over the next 10 years, according to a report in The Wall Street Journal.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.